These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27276984)

  • 1. Improved prediction of antibody VL-VH orientation.
    Marze NA; Lyskov S; Gray JJ
    Protein Eng Des Sel; 2016 Oct; 29(10):409-418. PubMed ID: 27276984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of VH-VL domain orientation for antibody variable domain modeling.
    Bujotzek A; Dunbar J; Lipsmeier F; Schäfer W; Antes I; Deane CM; Georges G
    Proteins; 2015 Apr; 83(4):681-95. PubMed ID: 25641019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blind prediction performance of RosettaAntibody 3.0: grafting, relaxation, kinematic loop modeling, and full CDR optimization.
    Weitzner BD; Kuroda D; Marze N; Xu J; Gray JJ
    Proteins; 2014 Aug; 82(8):1611-23. PubMed ID: 24519881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABangle: characterising the VH-VL orientation in antibodies.
    Dunbar J; Fuchs A; Shi J; Deane CM
    Protein Eng Des Sel; 2013 Oct; 26(10):611-20. PubMed ID: 23708320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural diversity in a human antibody germline library.
    Teplyakov A; Obmolova G; Malia TJ; Luo J; Muzammil S; Sweet R; Almagro JC; Gilliland GL
    MAbs; 2016; 8(6):1045-63. PubMed ID: 27210805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline-Dependent Antibody Paratope States and Pairing Specific V
    Fernández-Quintero ML; Kroell KB; Bacher LM; Loeffler JR; Quoika PK; Georges G; Bujotzek A; Kettenberger H; Liedl KR
    Front Immunol; 2021; 12():675655. PubMed ID: 34447370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V
    Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
    Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific attributes of the V
    Guloglu B; Deane CM
    Front Immunol; 2023; 14():1223802. PubMed ID: 37564639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. abYpap: improvements to the prediction of antibody VH/VL packing using gradient boosted regression.
    Boron VA; Martin ACR
    Protein Eng Des Sel; 2023 Jan; 36():. PubMed ID: 38015984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.
    Al Qaraghuli MM; Ferro VA
    J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27862476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate prediction of CDR-H3 loop structures of antibodies with deep learning.
    Chen H; Fan X; Zhu S; Pei Y; Zhang X; Zhang X; Liu L; Qian F; Tian B
    Elife; 2024 Jun; 12():. PubMed ID: 38921957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VH-VL orientation prediction for antibody humanization candidate selection: A case study.
    Bujotzek A; Lipsmeier F; Harris SF; Benz J; Kuglstatter A; Georges G
    MAbs; 2016; 8(2):288-305. PubMed ID: 26637054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted epitope specificity determined by variable region germline segment pairing in rodent antibody repertoires.
    Hsiao YC; Chen YJ; Goldstein LD; Wu J; Lin Z; Schneider K; Chaudhuri S; Antony A; Bajaj Pahuja K; Modrusan Z; Seshasayee D; Seshagiri S; Hötzel I
    MAbs; 2020; 12(1):1722541. PubMed ID: 32041466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen recognition by single-domain antibodies: structural latitudes and constraints.
    Henry KA; MacKenzie CR
    MAbs; 2018; 10(6):815-826. PubMed ID: 29916758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.
    Groves MA; Amanuel L; Campbell JI; Rees DG; Sridharan S; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2014; 6(1):236-45. PubMed ID: 24256948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody modeling assessment II. Structures and models.
    Teplyakov A; Luo J; Obmolova G; Malia TJ; Sweet R; Stanfield RL; Kodangattil S; Almagro JC; Gilliland GL
    Proteins; 2014 Aug; 82(8):1563-82. PubMed ID: 24633955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody humanization by structure-based computational protein design.
    Choi Y; Hua C; Sentman CL; Ackerman ME; Bailey-Kellogg C
    MAbs; 2015; 7(6):1045-57. PubMed ID: 26252731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human V
    Henry KA; Kim DY; Kandalaft H; Lowden MJ; Yang Q; Schrag JD; Hussack G; MacKenzie CR; Tanha J
    Front Immunol; 2017; 8():1759. PubMed ID: 29375542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.